On this page
Jerry D Reece
Insider
First SEC filing: March 14, 2013 · Latest: March 14, 2013
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2015 | MED | A | 1,250 | · | · | 6,250 Direct | +25.00% | Acquired | (price as of 2026-10-05) |
| Feb. 17, 2015 | MED | A | 315 | · | · | 8,792 Direct | +3.72% | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2014 | MED | A | 340 | · | · | 8,477 Direct | +4.18% | Acquired | (price as of 2026-10-05) |
| Sept. 30, 2014 | MED | A | 348 | · | · | 8,137 Direct | +4.47% | Acquired | (price as of 2026-10-05) |
| June 30, 2014 | MED | A | 375 | · | · | 7,789 Direct | +5.06% | Acquired | (price as of 2026-10-05) |
| March 31, 2014 | MED | A | 392 | · | · | 7,414 Direct | +5.58% | Acquired | (price as of 2026-10-05) |
| Feb. 5, 2014 | MED | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Feb. 5, 2014 | MED | A | 750 | · | · | 7,022 Direct | +11.96% | Acquired | (price as of 2026-10-05) |
| Dec. 31, 2013 | MED | A | 437 | · | · | 6,272 Direct | +7.49% | Acquired | (price as of 2026-10-05) |
| Sept. 30, 2013 | MED | A | 424 | · | · | 5,835 Direct | +7.84% | Acquired | (price as of 2026-10-05) |
| June 30, 2013 | MED | A | 373 | · | · | 5,411 Direct | +7.40% | Acquired | (price as of 2026-10-05) |
| March 31, 2013 | MED | A | 429 | · | · | 5,038 Direct | +9.31% | Acquired | (price as of 2026-10-05) |
| Feb. 19, 2013 | MED | A | 750 | · | · | 4,609 Direct | +19.44% | Acquired | (price as of 2026-10-05) |
| June 20, 2011 | MED | A | 1,482 | $22.40 | $33,197 | 2,048 Direct | +261.84% | Acquired | -47.9% (price as of 2026-10-05) |
| April 6, 2010 | MED | A | 566 | $26.52 | $15,010 | 566 Direct | · | Acquired | -56.0% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2015 | MED | Stock Option | Common Stock | $31.55 | Feb. 17, 2025 | 1,250 | Acquired |
| Feb. 5, 2014 | MED | Stock Option | Common Stock | $26.52 | Feb. 5, 2024 | 5,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).